These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 21193494)

  • 1. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia.
    Chuang YC; Sheng WH; Li SY; Lin YC; Wang JT; Chen YC; Chang SC
    Clin Infect Dis; 2011 Feb; 52(3):352-60. PubMed ID: 21193494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acinetobacter baumannii and Acinetobacter genospecies 13TU and 3 bacteraemia: comparison of clinical features, prognostic factors and outcomes.
    Lee YC; Huang YT; Tan CK; Kuo YW; Liao CH; Lee PI; Hsueh PR
    J Antimicrob Chemother; 2011 Aug; 66(8):1839-46. PubMed ID: 21653602
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outbreak in Croatia caused by a new carbapenem-resistant clone of Acinetobacter baumannii producing OXA-72 carbapenemase.
    Goic-Barisic I; Towner KJ; Kovacic A; Sisko-Kraljevic K; Tonkic M; Novak A; Punda-Polic V
    J Hosp Infect; 2011 Apr; 77(4):368-9. PubMed ID: 21316806
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular epidemiology of carbapenem-resistant Acinetobacter baumannii strains in intensive care units of multiple Mediterranean hospitals.
    Giannouli M; Tomasone F; Agodi A; Vahaboglu H; Daoud Z; Triassi M; Tsakris A; Zarrilli R
    J Antimicrob Chemother; 2009 Apr; 63(4):828-30. PubMed ID: 19223304
    [No Abstract]   [Full Text] [Related]  

  • 5. Identification of multidrug- and carbapenem-resistant Acinetobacter baumannii in Canada: results from CANWARD 2007.
    McCracken M; DeCorby M; Fuller J; Loo V; Hoban DJ; Zhanel GG; Mulvey MR
    J Antimicrob Chemother; 2009 Sep; 64(3):552-5. PubMed ID: 19578083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antimicrobial treatment and clinical outcome for infections with carbapenem- and multiply-resistant Acinetobacter baumannii around London.
    Livermore DM; Hill RL; Thomson H; Charlett A; Turton JF; Pike R; Patel BC; Manuel R; Gillespie S; Balakrishnan I; Barrett SP; Cumberland N; Twagira M;
    Int J Antimicrob Agents; 2010 Jan; 35(1):19-24. PubMed ID: 19910162
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emergence of carbapenem resistance in Acinetobacter baumannii in the Czech Republic is associated with the spread of multidrug-resistant strains of European clone II.
    Nemec A; Krízová L; Maixnerová M; Diancourt L; van der Reijden TJ; Brisse S; van den Broek P; Dijkshoorn L
    J Antimicrob Chemother; 2008 Sep; 62(3):484-9. PubMed ID: 18477708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Difference in imipenem, meropenem, sulbactam, and colistin nonsusceptibility trends among three phenotypically undifferentiated Acinetobacter baumannii complex in a medical center in Taiwan, 1997-2007.
    Liang-Yu C; Kuo SC; Liu CY; Luo BS; Huang LJ; Lee YT; Chen CP; Chen TL; Fung CP
    J Microbiol Immunol Infect; 2011 Oct; 44(5):358-63. PubMed ID: 21524973
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors and outcome analysis of acinetobacter baumannii complex bacteremia in critical patients.
    Lee HY; Chen CL; Wu SR; Huang CW; Chiu CH
    Crit Care Med; 2014 May; 42(5):1081-8. PubMed ID: 24394630
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrent bacteremia caused by the Acinetobacter calcoaceticus-Acinetobacter baumannii complex.
    Lai CC; Hsu HL; Tan CK; Tsai HY; Cheng A; Liu CY; Huang YT; Liao CH; Sheng WH; Hsueh PR
    J Clin Microbiol; 2012 Sep; 50(9):2982-6. PubMed ID: 22760035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genotypic analysis of Acinetobacter bloodstream infection isolates in a Turkish university hospital.
    Alp E; Esel D; Yildiz O; Voss A; Melchers W; Doganay M
    Scand J Infect Dis; 2006; 38(5):335-40. PubMed ID: 16709534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiologic characterization of nosocomial Acinetobacter baumannii infections in a Turkish university hospital by pulsed-field gel electrophoresis.
    Cetin ES; Durmaz R; Tetik T; Otlu B; Kaya S; Calişkan A
    Am J Infect Control; 2009 Feb; 37(1):56-64. PubMed ID: 18834735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic basis of resistance to aminoglycosides in Acinetobacter spp. and spread of armA in Acinetobacter baumannii sequence group 1 in Korean hospitals.
    Cho YJ; Moon DC; Jin JS; Choi CH; Lee YC; Lee JC
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):185-90. PubMed ID: 19361944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical features and molecular epidemiology of multidrug-resistant Acinetobacter calcoaceticus-A baumannii complex in a regional teaching hospital in Taiwan.
    Lin MF; Yang CM; Lin CH; Huang ML; Tu CC; Liou ML
    Am J Infect Control; 2009 Nov; 37(9):e1-3. PubMed ID: 19576662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence types of Portuguese carbapenem-resistant Acinetobacter baumannii isolates collected over 10 years.
    Da Silva GJ; Mendonça N; Batista G; Duarte A
    J Antimicrob Chemother; 2010 Oct; 65(10):2254-6. PubMed ID: 20656679
    [No Abstract]   [Full Text] [Related]  

  • 16. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection.
    Lee YT; Kuo SC; Yang SP; Lin YT; Tseng FC; Chen TL; Fung CP
    Clin Infect Dis; 2012 Jul; 55(2):209-15. PubMed ID: 22495546
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Carbapenem-non-susceptible Acinetobacter baumannii of sequence type 92 or its single-locus variants with a G428T substitution in zone 2 of the rpoB gene.
    Lee Y; Lee J; Jeong SH; Lee J; Bae IK; Lee K
    J Antimicrob Chemother; 2011 Jan; 66(1):66-72. PubMed ID: 21051374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OXA-23-producing Acinetobacter baumannii: a new hotspot of diversity in Rio de Janeiro?
    Grosso F; Carvalho KR; Quinteira S; Ramos A; Carvalho-Assef AP; Asensi MD; Peixe L
    J Antimicrob Chemother; 2011 Jan; 66(1):62-5. PubMed ID: 21051372
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increasing frequency of class 1 and 2 integrons in multidrug-resistant clones of Acinetobacter baumannii reveals the need for continuous molecular surveillance.
    Ramírez MS; Stietz MS; Vilacoba E; Jeric P; Limansky AS; Catalano M; Centrón D
    Int J Antimicrob Agents; 2011 Feb; 37(2):175-7. PubMed ID: 21177078
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibiotic-resistant Acinetobacter baumannii variants belonging to global clone 1.
    Post V; Hamidian M; Hall RM
    J Antimicrob Chemother; 2012 Apr; 67(4):1039-40. PubMed ID: 22279182
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.